Breaking News

Modicus Prime Raises Funding to Support Pharma 4.0 QC Software

Cloud software designed to scale GxP-compatible AI models for real-time quality control in commercial manufacturing.

By: Kristin Brooks

Managing Editor, Contract Pharma

Modicus Prime, resident at Johnson & Johnson Innovation – JLABS @ TMC, has received $3.5 million in funding led by Silverton Partners, with additional backing from Alumni Ventures and other leading venture firms. The funding follows the implementation of Modicus Prime’s mpVision, a Pharma 4.0 quality control technology, across multiple global pharmaceutical companies, CMOs, and CDMOs manufacturing biologics, cell and gene therapies, and vaccines.

The cloud software is designed to scale GxP-compatible AI models for real-time quality control in commercial manufacturing. 

As a hardware-agnostic software layer, mpVision is integrated into any camera-equipped device, ranging from microscopes to microflow imaging devices. By ensuring the identity, efficacy, and purity of drug products, mpVision aims to significantly reduce costs and waste from failed batches. Regulatory agencies recommend pharmaceutical companies implement more in-process monitoring to understand the state of their product at every stage of production. 

Taylor Chartier, Modicus Prime’s CEO, was selected among a group of industry experts to create an Artificial Intelligence Good Practice Guide for the pharmaceutical industry on behalf of the International Society for Pharmaceutical Engineering, ISPE. This guidance is projected to be heavily referenced by pharma’s quality units. In addition, Chartier is spearheading ISPE’s GxP AI Webinar Series with fellow industry experts, which is a 6-part webinar series on implementing AI/ML solutions in GxP environments, from initial concept to final deployment. 

As part of the financing round, Silverton Partners’ Roger Chen joins the Company’s board of directors. Roger Chen said, “This company is responding to the pharmaceutical industry’s current demands, delivering a welcomed cloud technology that’s already yielding practical results. We are very enthusiastic about supporting this movement.”

Modicus Prime will be using this new capital to further service their international pharmaceutical customers with additional customer support.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters